comparemela.com

Latest Breaking News On - Pimavanserin nuplazid - Page 1 : comparemela.com

Psychiatry in the News: March 2024

Here are some updates from the world of psychiatry throughout the month of March.

Johnj millerMichael thorpyPimavanserin nuplazidDrug administrationAlbert einstein college of medicineWake disorders centerAcadia pharmaceuticalsMontefiore medical centerPsychiatric timesNarcolepsy meets primaryOrphan drug designationSleep wake disorders centerAlbert einstein collegeCandidate pimavanserin failsAchieve primary efficacyStar advanced therapy

LSD Anxiety Win; Pimavanserin Schizophrenia Flop; Bright Light for Depression?

News and commentary from the psychiatry world

United statesNew yorkPimavanserin nuplazidAcadia pharmaceuticalsYork city children centerMontefiore medical centerHamilton anxiety rating scaleNature medicineMedical centerNew york city childrenLancet psychiatryAmerican journalNew york city

Mortality Advantage With Pimavanserin in Parkinson s Psychosis?

Use of pimavanserin was associated with 35% lower mortality for patients with Parkinson s disease–related psychosis compared with atypical antipsychotics, a large new real-world analysis shows.

United statesPimavanserin nuplazidAndrew mosholderAcadia pharmaceuticalsDrug administrationDrug evaluationMedscape medicalAmerican journalMedscape medical newsParkinsons diseaseAtypical antipsychoticsNursing homesUs food and drug administrationNited states food and drug administrationOff label indication

vimarsana © 2020. All Rights Reserved.